The current situation puts a bright light on the digitalization deficiencies of our health system. As the fight against COVID-19 continues, health organizations must find new ways of working. Unprecedented speed in putting digital capabilities and an agile mindset in place is now required to adapt efficiently and deliver valuable solutions – not only for the actual crisis. Zühlke takes a leading role in contributing to these solutions, being it by developing a COVID-19 tracing app or generally speaking by encouraging and enabling the usage of the latest digital technologies in the pharmaceutical industry.
can help you to
1. Accelerate clinical trials
Only 5% of all patients participate in clinical studies – and 30% of those participants drop out before all data is collected by the research group. This situation can be improved with the help of digital technologies.
read more …
2. Connect with patients
The share of clinical data with the pharmaceutical industry is hampered by a lack of trust along the society. Putting the patient into the center of all activities by giving them the control over their own data and offering improved patient outcomes with digital applications can help to build valuable relationships.
read more …
3. Better understand diseases
The entrance of big tech companies changes the healthcare landscape as they take a user-centric and data-driven approach on healthcare. What is needed, however, is a smart combination of biological know-how and digital solutions.
read more …
4. Efficiently Treat diseases
Not only drugs can treat diseases, also software and medical apps can be used as part of therapies to improve health outcomes.
read more …
5. Measure outcome
Legislation, regulations and payers increasingly demand proof of the effectiveness and efficiency of pharmaceuticals and medical products. The solution to that could be digital biomarkers that can measure the health outcome in real time.
read more …
At Zühlke, we are happy to help you develop medical grade data algorithms, connect you with patients and gain their trust, realize medical grade devices, build digital health platforms and accelerate the time to market of your products.
Why we are the
Innovation is our DNA. We support you in evaluating and realizing digital technologies within your organisation and product portfolio: we develop medical software, algorithms and devices customized for your specific needs. Customer satisfaction is our main goal, it is what drives us – and that is why we can look back onto more than 10.000 successful innovation projects during the last 50 years.
Strong partnerships with leading cloud providers such as Microsoft, Amazon and Google as well as a network of highly innovative partner companies guarantee that you get the technology that suits your demands.
- Top 5 pharma companies in Europe work with us
- Over 50 years of experience
- 1200 employees
- 176 nations
- 14 locations worldwide
- 10000 successful projects
- ISO 13485 compliant medical device development up to class III
Contact person Switzerland
Director Business Development & Head Health Industries
When Daniel Diezi joined Zühlke in 2016, he already had acquired more than 12 years of global healthcare experience and led digital transformation projects internationally. As advisory board member of a digital health think-tank, the Swiss MedTech Association and as chairman of the MedTech & Pharma platform, he takes a leading role in shaping the future of health.
Contact person Germany
Senior Business Development Manager and Industry Lead – Digital Healthcare and Life Sciences
Jan Horvat has a long track record in several strategic and operational management positions leading international product and software development alliances in the pharmaceutical and in various tech-industries. Together with his team, he is passionate about guiding healthcare clients to establish health-tech and digital business innovations along their patient´s and enterprise value chains.
Contact person Austria
Dr. Nikolaus Kawka
CEO Austria and Partner
Having a PhD in physics from TU Wien, Dr. Nikolaus Kawka has a strong background in balancing business development and finding solutions in IT and Tech environments. He joined Zühlke as CEO of Zühlke Austria in 2011 and became a partner in 2018. Now, he is looking forward to reshaping healthcare in Austria through digital technology and help clients to face digital challenges together.
Meaningful market research combines modern methods with individual solutions. We start with your questions and deliver, absolutely reliably and on time, “state of the art” market research from a single source.